Market Cap

Ocular Therapeutix, Inc. Market Capitalization:

$1.03 Billion

USD as of July 1, 2024

business Ocular Therapeutix, Inc. Company Profile

Ocular Therapeutix, Inc. Main Stock Listing

NASDAQ: OCUL

Market Capitalization History of Ocular Therapeutix, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Ocular Therapeutix, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $505.3 M 58.87%
Jan. 1, 2023 $318.1 M -27.03%
Jan. 1, 2022 $435.9 M -68.82%
Jan. 1, 2021 $1.40 B 316.28%
Jan. 1, 2020 $335.8 M 15.34%
Jan. 1, 2019 $291.1 M -30.90%
Jan. 1, 2018 $421.2 M -16.62%
Jan. 1, 2017 $505.2 M 7.19%
Jan. 1, 2016 $471.3 M -79.92%
Jan. 1, 2015 $2.35 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Ocular Therapeutix, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Ocular Therapeutix, Inc. has the following listings and related stock indices.


Stock: NASDAQ: OCUL

Stock: FSX: 0OT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.